The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Arber, Daniel A., Orazi, Attilio, Hasserjian, Robert, Thiele, Jürgen, Borowitz, Michael J., Le Beau, Michelle M., Bloomfield, Clara D., Cazzola, Mario +1 more·2016·Blood

DOI 10.1182/blood-2016-03-643544

Cited by (1,019)

Items 501–600 of 1,019

Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia
Mackenzie Bloom, Jamie L. Maciaszek, Mary Egan Clark, Ching‐Hon Pui, Kim E. Nichols · 2019 · Expert Review of Hematology
Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes
Yasunobu Nagata, Ran Zhao, Hassan K. Awada, Cassandra M Kerr, Inom Mirzaev, Sunisa Kongkiatkamon, Aziz Nazha, Hideki Makishima, Tomas Radivoyevitch, Jacob G. Scott et al. · 2020 · Blood
T-cell ligands modulate the cytolytic activity of the CD33/CD3 BiTE antibody construct, AMG 330
G S Laszlo, Chelsea J. Gudgeon, Kimberly H. Harrington, Roland B. Walter · 2015 · Blood Cancer Journal
Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis
Francesca Palandri, Roberto Latagliata, Nicola Polverelli, Alessia Tieghi, Monica Crugnola, B. Martino, Margherita Perricone, Massimo Breccia, Emanuela Ottaviani, Nicoletta Testoni et al. · 2015 · Leukemia
TP53 mutations predict decitabine‐induced complete responses in patients with myelodysplastic syndromes
Chunkang Chang, Youshan Zhao, Feng Xu, Juan Guo, Zheng Zhang, Qi He, Dong Wu, Lingyun Wu, Jiying Su, Lu‐Xi Song et al. · 2016 · British Journal of Haematology
The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis
Catherine A. Cargo, Matthew J. Cullen, Jan Taylor, Mike Short, Paul Glover, Suzan Van Hoppe, Alex G. Smith, Paul Evans, Simon Crouch · 2019 · Blood
The molecular mechanics of mixed lineage leukemia
Robert K. Slany · 2016 · Oncogene
Meta-analysis of chromosomal aberrations as a biomarker of exposure in healthcare workers occupationally exposed to antineoplastic drugs
Christine Roussel, Kristine L. Witt, Peter B. Shaw, Thomas H. Connor · 2017 · Mutation Research/Reviews in Mutation Research
(A Critical Appraisal of) Classification of Hypereosinophilic Disorders
Jean‐Emmanuel Kahn, Matthieu Groh, Guillaume Lefèvre · 2017 · Frontiers in Medicine
CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia
Woori Jang, Joonhong Park, Ahlm Kwon, Hayoung Choi, Jiyeon Kim, Dong‐Gun Lee, Eunhee Han, Dong Wook Jekarl, Hyojin Chae, Kyungja Han et al. · 2019 · Experimental & Molecular Medicine
MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen
Haris Ali, Ibrahim Taha Aldoss, Dongyun Yang, Sally Mokhtari, Samer K. Khaled, Ahmed M. Aribi, Michelle Afkhami, Monzr M. Al Malki, Thai M. Cao, Matthew Genyeh Mei et al. · 2019 · Blood Advances
Chronic myelogenous leukemia, a still unsolved problem: pitfalls and new therapeutic possibilities
Sylwia Flis, Tomasz Chojnacki · 2019 · Drug Design Development and Therapy
Age-Associated TET2 Mutations: Common Drivers of Myeloid Dysfunction, Cancer and Cardiovascular Disease
Christina K. Ferrone, Mack Blydt-Hansen, Michael J. Rauh · 2020 · International Journal of Molecular Sciences
DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch
Michaela Nováková, Marketa Kubricanova Zaliova, Karel Fišer, Barbora Vakrmanová, Lucie Slámová, Alena Musilová, Monika Brüggemann, Matthias Ritgen, Eva Froňková, Tomáš Kalina et al. · 2020 · Haematologica
A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemia
Graeme Smith, Jane F. Apperley, Dragana Milojković, Nicholas C.P. Cross, Letizia Foroni, Jenny Byrne, A. Goringe, Anupama Rao, Jamshid Sorouri Khorashad, Hugues de Lavallade et al. · 2020 · British Journal of Haematology
Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication
Nikolaus Jahn, Tobias Terzer, Eric Sträng, Anna Dolnik, Sibylle Cocciardi, Ekaterina Panina, Andrea Corbacioglu, Julia Herzig, Daniela Weber, Anika Schrade et al. · 2020 · Blood Advances
Acute Myeloid Leukemia Stem Cells: Origin, Characteristics, and Clinical Implications
Nathaniel A. Long, Upendarrao Golla, Arati Sharma, David F. Claxton · 2022 · Stem Cell Reviews and Reports
Homoharringtonine (omacetaxine mepesuccinate) as an adjunct forFLT3-ITD acute myeloid leukemia
Stephen S.Y. Lam, Eric S.K. Ho, Alex Bai-Liang He, Wui-Wing Wong, Chae Yin Cher, Nelson K.L. Ng, Cheuk‐Him Man, Harinder Gill, Alice Man Sze Cheung, Ho‐Wan Ip et al. · 2016 · Science Translational Medicine
DNMT3A mutations are associated with inferior overall and leukemia‐free survival in chronic myelomonocytic leukemia
Mrinal M. Patnaik, Daniela Barraco, Terra L. Lasho, Christy M. Finke, Curtis A. Hanson, Rhett P. Ketterling, Naseema Gangat, Ayalew Tefferi · 2016 · American Journal of Hematology
Cytarabine dose in the consolidation treatment of AML: a systematic review and meta-analysis
Kinkini N. Magina, Gudrun Pregartner, Armin Zebisch, Albert Wölfler, Peter Neumeister, Hildegard T. Greinix, Andrea Berghold, Heinz Sill · 2017 · Blood
A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms
Rita Elias Assi, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Jörge E. Cortes, Naveen Pemmaraju, Xuemei Wang, Graciela M. Nogueras‐González, Elias Joseph Jabbour, Prithviraj Bose, Tapan Mahendra Kadia et al. · 2017 · American Journal of Hematology
Classification and risk assessment in AML: integrating cytogenetics and molecular profiling
Matahi Moarii, Elli Papaemmanuil · 2017 · Hematology
AreBTKandPLCG2mutations necessary and sufficient for ibrutinib resistance in chronic lymphocytic leukemia?
Benjamin L. Lampson, Jennifer R. Brown · 2018 · Expert Review of Hematology
Next Generation Sequencing in AML—On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?
Michael Leisch, Bettina Jansko, Nadja Zaborsky, Richard Greil, Lisa Pleyer · 2019 · Cancers
CEBPA –double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features
Francesco Mannelli, Vanessa Ponziani, Sara Bencini, Maria Ida Bonetti, Matteo Benelli, Ilaria Cutini, Giacomo Gianfaldoni, Barbara Scappini, Fabiana Pancani, Matteo Piccini et al. · 2016 · Haematologica
JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms
Tata Nageswara Rao, Nils Hansen, Julian Hilfiker, Shivam Rai, Julia-Magdalena Majewska, Danijela Leković, Deniz Gezer, Nicola Daniele Andina, Serena Galli, Teresa Cassel et al. · 2019 · Blood
Targeted Therapies for Pediatric AML: Gaps and Perspective
Annalisa Lonetti, Andrea Pession, Riccardo Masetti · 2019 · Frontiers in Pediatrics
Characteristics of DNMT3A mutations in acute myeloid leukemia
Dong Jin Park, Ahlm Kwon, Byung‐Sik Cho, Hee‐Je Kim, Kyung-Ah Hwang, Myungshin Kim, Yonggoo Kim · 2020 · Blood Research
Clinical Implications of Inflammation in Acute Myeloid Leukemia
Christian Récher · 2021 · Frontiers in Oncology
Chronic Myeloid Leukemia, from Pathophysiology to Treatment-Free Remission: A Narrative Literature Review
Ikhwan Rinaldi, Kevin Winston · 2023 · Journal of Blood Medicine
Survival of patients with mixed phenotype acute leukemias: A large population-based study
Runhua Shi, Reinhold Munker · 2015 · Leukemia Research
Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature
Andrea Kuendgen, Catharina Müller‐Thomas, Michael Lauseker, Torsten Haferlach, Petra Urbaniak, Thomas A. Schroeder, Carolin Brings, Michael Wulfert, Manja Meggendorfer, Barbara Hildebrandt et al. · 2018 · Oncotarget
Current and emerging strategies for management of myelodysplastic syndromes
Saygin, Caner, Carraway, Hetty E. · 2021 · Blood Reviews
Anaphylactic reactions after discontinuation of hymenoptera venom immunotherapy: a clonal mast cell disorder should be suspected
Bonadonna, Patrizia, Zanotti, Roberta, Pagani, Mauro, Bonifacio, Massimiliano, Scaffidi, Luigi, Olivieri, Elisa, Franchini, Maurizio, Reccardini, Federico, Costantino, Maria Teresa, Roncallo, Chiara et al. · 2018 · The Journal of Allergy and Clinical Immunology: In Practice
Mitochondrial dependency in progression of acute myeloid leukemia.
N. Basak, S. Banerjee · 2015 · Mitochondrion (Amsterdam. Print)
The 2016 revision to the World Health Organization classification of myelodysplastic syndromes
Ming Hong, Guangsheng He · 2017 · Journal of Translational Internal Medicine
Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk
Amit Sud, Subhayan Chattopadhyay, Hauke Thomsen, Kristina Sundquist, Jan Sundquist, Richard S. Houlston, Kari Hemminki · 2019 · Blood
Management of Chronic Myeloid Leukemia in Advanced Phase
Massimiliano Bonifacio, Fabio Stagno, Luigi Scaffidi, Mauro Krampera, Francesco Di Raimondo · 2019 · Frontiers in Oncology
Mixed‐phenotype acute leukemia: A cohort and consensus research strategy from the Children’s Oncology Group Acute Leukemia of Ambiguous Lineage Task Force
Etan Orgel, Thomas Alexander, Brent Lee Wood, Samir B. Kahwash, Meenakshi Devidas, Yunfeng E. Dai, Todd A. Alonzo, Charles Grenfell Mullighan, Hiroto Inaba, Stephen P. Hunger et al. · 2019 · Cancer
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry
Benjamin De Valence, Marion Delaune, Yann Nguyen, Vincent Jachiet, Maël Heiblig, Alexis Jean, Stanislas Riescher, Pierrick Henneton, Philippe Guilpain, Nicolas SCHLEINITZ et al. · 2023 · Annals of the Rheumatic Diseases
Monocyte subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosis
Chetasi Talati, Ling Zhang, Ghada Shaheen, Andrew Tucker Kuykendall, Markus Ball, Qing Zhang, Jeffrey E. Lancet, Kenneth S. Zuckerman, Alan F. List, Rami S. Komrokji et al. · 2017 · Blood
Mixed-Phenotype Acute Leukemia: Diagnostic Criteria and Pitfalls
Nathan J. Charles, Daniel F. Boyer · 2017 · Archives of Pathology & Laboratory Medicine
Myeloid/lymphoid neoplasms with FGFR1 rearrangement
Paolo Strati, Guilin Tang, Dzifa Y. Duose, Saradhi Mallampati, Rajyalakshmi Luthra, Keyur Pravinchandra Patel, Mohammad Hussaini, Abu‐Sayeef Mirza, Rami S. Komrokji, Stephen T. Oh et al. · 2017 · Leukemia & lymphoma/Leukemia and lymphoma
Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients
Tucker W. Coston, Prateek A. Pophali, Rangit Reddy Vallapureddy, Terra L. Lasho, Christy M. Finke, Rhett P. Ketterling, Ryan Michael Carr, Moritz Binder, Abhishek Avinash Mangaonkar, Naseema Gangat et al. · 2019 · American Journal of Hematology
The Biology of B-Progenitor Acute Lymphoblastic Leukemia
Kathryn G. Roberts, Charles Grenfell Mullighan · 2019 · Cold Spring Harbor Perspectives in Medicine
Oral Manifestations and Complications in Childhood Acute Myeloid Leukemia
Francisco Cammarata‐Scalisi, Katia Girardi, Luisa Strocchio, Pietro Merli, Annelyse Martine Garret-Bernardin, Angela Galeotti, Fabio Magliarditi, Alessandro Inserra, Michele Callea · 2020 · Cancers
Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses
Trine Alma Knudsen, Vibe Skov, Kristen E. Stevenson, Lillian L. Werner, William Duke, Charles Laurore, Christopher James Gibson, Anwesha Nag, Aaron R. Thorner, Bruce M. Wollison et al. · 2021 · Blood Advances
Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2-mutant myelodysplastic syndrome
Courtney Denton Dinardo, Sangeetha Venugopal, Curtis Andrew Lachowiez, Koichi Takahashi, Sanam Loghavi, Guillermo Montalban Bravo, Xuemei Wang, Hetty E. Carraway, Mikkael Aaron Sekeres, Ameenah Sukkur et al. · 2022 · Blood Advances
The multifaceted functions of C/EBPα in normal and malignant haematopoiesis
Ewa Ohlsson, Mikkel Bruhn Schuster, Marie Sigurd Hasemann, Bo Torben Porse · 2015 · Leukemia
DNA of Erythroid Origin Is Present in Human Plasma and Informs the Types of Anemia
W.K. Lam, Wanxia Gai, Kun Sun, Raymond S. M. Wong, Rebecca W.Y. Chan, Peiyong Jiang, Natalie Pui Ha Chan, Winnie W. I. Hui, Anthony W.H. Chan, Cheuk‐Chun Szeto et al. · 2017 · Clinical Chemistry
Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens
John Francis Seymour, Hartmut Döhner, Aleksandra K. Butrym, Agnieszka Wierzbowska, Dominik Selleslag, Jun Ho Jang, Rajat Kumar, James D. Cavenagh, Andre C. Schuh, Anna Candoni et al. · 2017 · BMC Cancer
TET2 deficiency leads to stem cell factor–dependent clonal expansion of dysfunctional erythroid progenitors
Xiaoli Qu, Shijie Zhang, Shihui Wang, Yaomei Wang, Wei Li, Yumin Huang, Huizhi Zhao, Xiuyun Wu, Chao An, Xinhua Guo et al. · 2018 · Blood
Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53
Bridget Kelly Marcellino, Ronald Hoffman, Joseph Tripodi, Min Lü, Heidi Kosiorek, John O Mascarenhas, Raajit K. Rampal, Amylou Constance Dueck, Vesna Najfeld · 2018 · Blood Advances
BCR/ABL1 –like acute lymphoblastic leukemia: How to diagnose and treat?
Sabina Chiaretti, Monica Messina, Robin Foà · 2018 · Cancer
Omalizumab therapy for mast cell-mediator symptoms in patients with ISM, CM, MMAS, and MCAS
Lemal, Richard, Fouquet, Guillemette, Terriou, Louis, Vaes, Mélanie, Livideanu, Cristina Bulai, Frenzel, Laurent, Barete, Stéphane, Canioni, Danielle, Lhermitte, Ludovic, Rossignol, Julien et al. · 2019 · The Journal of Allergy and Clinical Immunology In Practice
<i>JAK2</i>-V617F and interferon-α induce megakaryocyte-biased stem cells characterized by decreased long-term functionality
Rao, Tata Nageswara, Hansen, Nils, Stetka, Jan, Luque Paz, Damien, Kalmer, Milena, Hilfiker, Julian, Endele, Max, Ahmed, Nouraiz, Kubovcakova, Lucia, Rybarikova, Margareta et al. · 2021 · Blood
Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms
Amy V. Jones, Daniel Ward, Matthew Lyon, William C.Y. Leung, Alison Callaway, Andrew Chase, Carolyn L. Dent, Helen White, Hans Günter Drexler, Jyoti Nangalia et al. · 2014 · Leukemia Research
Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China
Xuepeng Qi, Guohong Han, Xiaozhong Guo, Valerio De Stefano, K. Xu, Zhaojun Lu, Hao Xu, Andrea Mancuso, W. Zhang, Xinwei Han et al. · 2016 · Alimentary Pharmacology & Therapeutics
Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Ruben A. Mesa, Catriona H. M. Jamieson, Ravi Bhatia, Michael W. Deininger, Aaron Thomas Gerds, Ivana Gojo, Jason R. Gotlib, Krishna Gundabolu, Gabriela Soriano Hobbs, Rebecca B. Klisovic et al. · 2016 · Journal of the National Comprehensive Cancer Network
A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis
Lucia Masárová, Srđan Verstovšek, Juliana E. Hidalgo‐Lόpez, Naveen Pemmaraju, Prithviraj Bose, Zeev E. Estrov, Elias Joseph Jabbour, Farhad Ravandi‐Kashani, Koichi Takahashi, Jörge E. Cortes et al. · 2018 · Blood
Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden
Theodoros Karantanos, Shruti Chaturvedi, Evan M. Braunstein, Jerry L. Spivak, Linda M S Resar, Styliani Karanika, Donna Marie Williams, Ophelia C. Rogers, Christopher D. Gocke, Alison R. Moliterno · 2020 · Blood Advances
LncRNA SNHG3, a potential oncogene in human cancers
Bin Xu, Jie Mei, Wei Ji, Zheng Bian, Jiantong Jiao, Jun Sun, Junfei Shao · 2020 · Cancer Cell International
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study
Javier I. Muñoz‐González, Iván Álvarez‐Twöse, María Jara‐Acevedo, Roberta Zanotti, Cecelia Perkins, Mohamad Jawhar, Wolfgang R. Sperr, Khalid Shoumariyeh, Juliana Schwaab, Georg Greiner et al. · 2021 · The Lancet Haematology
Effects of family participatory dignity therapy on the psychological well-being and family function of patients with haematologic malignancies and their family caregivers: A randomised controlled trial
Chunfeng Wang, Jingyi Chen, Ying Wang, Wenkui Xu, Mengting Xie, Yong Wu, Rong Hu · 2021 · International Journal of Nursing Studies
Antileukemic Activity of 2-Deoxy- d -Glucose through Inhibition of N-Linked Glycosylation in Acute Myeloid Leukemia with FLT3-ITD or c-KIT Mutations
Clément Larrue, Estelle Saland, François Vergez, Nizar Serhan, Éric Delabesse, Véronique Mansat‐De Mas, Jérôme Tamburini, Stéphane Manenti, Jean‐Emmanuel Sarry, Christian Récher · 2015 · Molecular Cancer Therapeutics
The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia
Jie Zhao, Jianwei Liang, Hui-liang Xue, Shuhong Shen, Jing Chen, Yanjing Tang, Lisha Yu, Huanhuan Liang, Long-Jun Gu, Jingyan Tang et al. · 2018 · Leukemia
Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia
Adnan Awad, Shady, Kankainen, Matti, Ojala, Teija, Koskenvesa, Perttu, Eldfors, Samuli, Ghimire, Bishwa, Kumar, Ashwini, Kytölä, Soili, Kamel, Mahmoud M., Heckman, Caroline A. et al. · 2020 · Blood Advances
MicroRNAs and tRNA-derived fragments predict the transformation of myelodysplastic syndromes to acute myeloid leukemia
Yan Ping Guo, Stephen Anthony Strickland, Sanjay Ram Mohan, Shaoying Li, Amma Bosompem, Kasey C. Vickers, Shilin Zhao, Quanhu Sheng, Annette S. Kim · 2017 · Leukemia & lymphoma/Leukemia and lymphoma
Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia
Pallavi Kanwar Galera, Alina Dulau‐Florea, Katherine R. Calvo · 2019 · International Journal of Laboratory Hematology
MLL-Rearranged Acute Leukemia with t(4;11)(q21;q23)—Current Treatment Options. Is There a Role for CAR-T Cell Therapy?
Oliver Britten, Denise Ragusa, Sabrina Tosi, Yasser Mostafa Kamel · 2019 · Cells
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T‐cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study
Anna Candoni, Davide Lazzarotto, Felicetto Ferrara, Antonio Curti, Federico Lussana, Cristina Papayannidis, Maria Ilaria Del Principe, Massimiliano Bonifacio, Federico Mosna, Mario Delia et al. · 2020 · American Journal of Hematology
Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm
Naveen Pemmaraju, Marina Y Konopleva · 2020 · Blood Advances
Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA , PDGFRB , or FGFR1 or With PCM1-JAK2
Olga Pozdnyakova, Attilio Orazi, Katalin Kelemen, Rebecca L. King, Kaaren K. Reichard, Fiona E. Craig, Leticia Quintanilla‐Martínez, Lisa M. Rimsza, Tracy I. George, Hans-Peter Horny et al. · 2020 · American Journal of Clinical Pathology
Langerhans Cell Histiocytosis and Langerhans Cell Sarcoma: Current Understanding and Differential Diagnosis
Hirokazu Nakamine, Mitsunori Yamakawa, Tadashi Yoshino, Takaya Fukumoto, Yasunori Enomoto, Itaru Matsumura · 2016 · Journal of the Japan Society of the Reticuloendothelial System
Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes
Aziz Nazha, Karam Al-Issa, Betty K. Hamilton, Tomas Radivoyevitch, Aaron Thomas Gerds, Sudipto Mukherjee, Vera Ademà, A. Zarzour, Nour K. Abuhadra, Bhumika J. Patel et al. · 2017 · Leukemia
The underappreciated risk of thrombosis and bleeding in patients with myelofibrosis: a review
Devendra Kc, Lorenzo Falchi, Srđan Verstovšek · 2017 · Annals of Hematology
Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results
Srđan Verstovšek, Francesco Passamonti, Alessandro Rambaldi, Giovanni Barosi, Elisa Rumi, Elisabetta Gattoni, Lisa Pieri, Huiling Zhen, Muriel Granier, Albert Assad et al. · 2017 · Blood
Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene U2af1
Dennis Liang Fei, Tao Zhen, Benjamin Heath Durham, John R. Ferrarone, Tuo Zhang, Lisa J Garrett, Akihide Yoshimi, Omar Ibrahim Abdel-Wahab, Robert K. Bradley, Paul Liu et al. · 2018 · Proceedings of the National Academy of Sciences
Introducing whole-genome sequencing into routine cancer care: the Genomics England 100 000 Genomes Project
Clare Turnbull · 2018 · Annals of Oncology
Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy
Guillermo Montalban Bravo, Rashmi Kanagal‐Shamanna, Caleb A. Class, Koji Sasaki, Farhad Ravandi, Jörge E. Cortes, Naval Guastad Daver, Koichi Takahashi, Nicholas James Short, Courtney Denton Dinardo et al. · 2020 · American Journal of Hematology
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
Jason R. Schwartz, Jing Ma, Jennifer L. Kamens, Tamara Westover, Michael P. Walsh, Samuel W. Brady, J. Robert Michael, Xiaolong Chen, Lindsey E. Montefiori, Guangchun Song et al. · 2021 · Nature Communications
Ophthalmologic manifestations as the initial presentation of chronic myeloid leukemia: A review
Mohamed A. Yassin, Fateen Ata, Shehab Mohamed, Ameen Alkhateeb, Usman Naeem, Ahmed Qatami, Abdulqadir J. Nashwan, Liam Joseph Fernyhough · 2021 · Survey of Ophthalmology
Idasanutlin Plus Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia: Results of the MIRROS Trial
Marina Y Konopleva, Christoph Röllig, Jamie D. Cavenagh, Dries Deeren, Larisa Girshova, Jürgen Krauter, Giovanni Martinelli, Pau Montesinos, Jonas Schäfer, Oliver Gerhard Ottmann et al. · 2022 · Blood Advances
Modulation of the PI3K/Akt signaling pathway by resveratrol in cancer: molecular mechanisms and therapeutic opportunity
Neda Hedayati, Mohamad Hosein Safari, Yaser Eshaghi Milasi, Samaneh Kahkesh, Najma Farahani, Seyedeh Mahdieh Khoshnazar, Zahra Dorostgou, Elmira Alaei, Mina Alimohammadi, Payman Rahimzadeh et al. · 2025 · Discover Oncology
Characteristics of Sweet Syndrome in Patients With Acute Myeloid Leukemia
Syed Mohammad Ali Kazmi, Naveen Pemmaraju, Keyur Pravinchandra Patel, Philip R Cohen, Naval Guastad Daver, Kathy M. Tran, Farhad Ravandi, Madeleine A. Duvic, Guillermo Garcia‐Manero, Sherry A. Pierce et al. · 2014 · Clinical Lymphoma Myeloma & Leukemia
Pre‐fibrotic/early primary myelofibrosis vs. WHO‐defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease
Georg Jeryczynski, Jürgen Thiele, Bettina Gisslinger, Albert Wölfler, Martin Schalling, Andreas Gleiß, Sonja Burgstaller, Veronika Buxhofer‐Ausch, Thamer Sliwa, Ernst Schlögl et al. · 2017 · American Journal of Hematology
The incidence of acute myeloid leukemia in Calgary, Alberta, Canada: a retrospective cohort study
Andrea Christine Shysh, Leonard Tu Nguyen, Maggie Guo, Marcus M. Vaska, Christopher T Naugler, Fariborz Rashid-Kolvear · 2017 · BMC Public Health
An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL)
Maliha Khan, Rabbia L. Siddiqi, Kiran Naqvi · 2018 · Annals of Hematology
SIRT3 deacetylase activity confers chemoresistance in AML via regulation of mitochondrial oxidative phosphorylation
Jiao Ma, Bin Liu, Dan Yu, Yong Zuo, Rong Cai, Jianmin Yang, Jinke Cheng · 2019 · British Journal of Haematology
The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution
Singhal, Deepak, Wee, Li Yan A., Kutyna, Monika M., Chhetri, Rakchha, Geoghegan, Joel, Schreiber, Andreas W., Feng, Jinghua, Wang, Paul P.-S., Babic, Milena, Parker, Wendy T. et al. · 2019 · Leukemia
Immune Mechanisms in Myelodysplastic Syndrome
Andreas Birkedal Glenthøj, Andreas Due Ørskov, Jakob Hansen, Sine Reker Hadrup, Casey Lee O'Connell, Kirsten Grønbæk · 2016 · International Journal of Molecular Sciences
Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies
Luiza Handschuh · 2019 · Journal of Oncology
Nucleophosmin 1 Mutations in Acute Myeloid Leukemia
Jabra G. Zarka, Nicholas James Short, Rashmi Kanagal‐Shamanna, Ghayas C. Issa · 2020 · Genes
A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia
Anuradha Kirtonia, Gouri Pandya, Gautam Sethi, Amit Kumar Pandey, Bhudev Chandra Das, Manoj Garg · 2020 · Journal of Molecular Medicine
AML with Myelodysplasia-Related Changes: Development, Challenges, and Treatment Advances
Kristin Lynn Koenig, Kieran D. Sahasrabudhe, Audrey M. Sigmund, Bhavana Bhatnagar · 2020 · Genes
Mechanisms of Immune Evasion in Acute Lymphoblastic Leukemia
Agata Karolina Pastorczak, Krzysztof Domka, Klaudyna Fidyt, Martyna Poprzeczko, Małgorzata Firczuk · 2021 · Cancers
The incidence and prevalence of patients with paroxysmal nocturnal haemoglobinuria and aplastic anaemia PNH syndrome: A retrospective analysis of the UK’s population‐based haematological malignancy research network 2004‐2018
Stephen John Richards, Daniel Painter, Anita J. Dickinson, Morag Griffin, Talha Munir, Louise Arnold, Daniel Payne, Alexandra Pike, Petra Muus, Anita Hill et al. · 2021 · European Journal Of Haematology
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT
Carmelo Gurnari, Linda Köster, Laurien G.A. Baaij, Maël Heiblig, Ibrahim Yakoub‐Agha, Matthew P. Collin, Jakob Robert Passweg, Claude‐Eric Bulabois, Anjum Bashir Khan, Michael L. Loschi et al. · 2024 · Blood Advances
Genomics of Myeloproliferative Neoplasms
Katerina Zoi, Nicholas C.P. Cross · 2017 · Journal of Clinical Oncology
Genetic Risk Assessment in Myeloproliferative Neoplasms
Ayalew Tefferi, Alessandro Maria Vannucchi · 2017 · Mayo Clinic Proceedings